Skip to content

Efficacy of Gamma - tACS on Cognition and Craving in Alcohol Use Disorder

Efficacy of Gamma - tACS on Cognition and Craving in Alcohol Use Disorder: A Sham Controlled Study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058609
Enrollment
40
Registered
2023-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F102- Alcohol dependence

Interventions

Intervention1: Active gamma tACS: ACTIVE GAMMA tACS TO PATIENTS WILL BE GIVEN FOR 5 CONSECUTIVE DAYS IN A WEEK FOR TWO CONSECUTIVE WEEKS FOR 20 MIN. Control Intervention1: Sham gamma tACS: SHAM GAMMA

Sponsors

Central Institute of Psychiatry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male patients diagnosed with Alcohol Dependence Syndrome as per International Classification of Disease - 11th revision - Diagnostic Criteria for Research (WHO, 2022). 2. Male with Alcohol Dependence aged between 18 to 60 years. 3. Severity of Alcohol Dependence Questionnaire (SADQ) in Male with Alcohol dependence greater than 16 4. The Clinical Institute Withdrawal Assessment for Alcohol (revised version) in Male with Alcohol dependence CIWA-Ar lesser than 10. 5. Right-handed 6. Male with Alcohol dependence who give informed consent. 7. Patients will be screened for cognitive deficit with Montreal Cognitive Assessment Test (MoCA). Cut off score is =25.

Exclusion criteria

Exclusion criteria: 1. Male with Alcohol dependence having any other co-morbid substance dependence except nicotine and caffeine. 2. Male with Alcohol dependence having any medical illness. 3. Male with Alcohol dependence having any other psychiatric illness, dementia, psychotic disorder, 4. Male with Alcohol dependence who are on any psychotropic medication or any anticraving medication in 2 weeks preceding and during the study. 5. Clinically diagnosed intellectual disability. 6. Past history of significant head injury. 7. Past history of epilepsy(Patients with history of alcohol withdrawal seizure will be included). 8. HAMD Score = 8.

Design outcomes

Primary

MeasureTime frame
Improvement of cognitive deficits in patients with Alcohol Use Disorder as response to Gamma-tACS.Timepoint: Improvement of cognitive deficits in patients with Alcohol Use Disorder as response to Gamma-tACS will be assessed at 0 week(Baseline) and 2 week

Secondary

MeasureTime frame
Improvement of craving in patients with Alcohol Use Disorder as response to Gamma-tACS.Timepoint: SYMPTOM SEVERITY WILL BE ASSESSED AT BASELINE WITH ACQ-SF-R, CGI-I before giving gamma tACs andPOST GAMMA tACS ASSESSMENT FOR SYMPTOM WITH ACQ-SF-R, CGI-I WILL BE REPEATED AT THE END OF 10 SESSIONS OF GAMM tACS.

Countries

India

Contacts

Public ContactDr Alok Pratap

Central Institute of Psychiatry

dralokpratap@gmail.com7781803812

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026